Kentucky regulatory summary
| Topic | Status | What it means for IV therapy |
|---|---|---|
| Corporate Practice of Medicine | Moderate | Kentucky’s professional entity rules limit ownership of professional service corporations to licensees, and the Kentucky Board of Medical Licensure disciplines physicians who cede clinical control. Lay investors typically use a management company.KRS Chapter 311 (physicians); KRS Chapter 274 (professional service corporations) |
| NP practice authority | Reduced | APRNs prescribe non-scheduled legend drugs under a Collaborative Agreement for Prescriptive Authority for Nonscheduled drugs (CAPA-NS) for their first four years; after that, CAPA-NS is no longer required. Controlled substances still need a CAPA-CS.KRS 314.042 |
| RN IV administration & delegation | Order required | KBN advisory opinion guidance on IV therapy and elective IV hydration expects an order from an authorized prescriber after a patient assessment, with the RN responsible for competence and for declining unsafe orders.Kentucky Board of Nursing advisory opinion statements on IV therapy |
| Good Faith Exam / telehealth | Strict | We treat Kentucky as strict: plan on a prescriber assessment before each new patient’s first infusion and before any prescription additive. Telehealth assessments must meet KBML standards.KRS Chapter 311; Kentucky Board of Medical Licensure regulations |
| Board of Pharmacy & USP <797> | Standard | The Kentucky Board of Pharmacy regulates compounding and drug distribution. Clinic mixing should stay within USP <797> immediate-use limits.KRS Chapter 315 (pharmacists and pharmacies) |
| Nurse Licensure Compact | Member | Kentucky shares the compact with Ohio, Indiana, Tennessee, Virginia and Missouri, but not Illinois.Nurse Licensure Compact (NCSBN) |
Practice setup at a glance
| CPOM tier | Moderate CPOM |
|---|---|
| Typical entity structure | Physician- or NP-owned PC/PLLC; MSO common for non-clinical investors |
| NP practice authority | Reduced (collaborative agreement) |
| Medical director retainer | $900–$1,600 per month (hydration/vitamin menu to NAD+/multi-nurse fleet) |
| Good Faith Exam | Synchronous prescriber evaluation expected before new patients and Rx drips · $27–$35 per telehealth clearance |
| Pharmacy enforcement | Standard: USP <797> immediate-use limits and 503B/503A sourcing apply |
| Nurse Licensure Compact | Compact member |
Practice setup blueprint in Kentucky
Kentucky IV practices are typically owned by a physician, or by an APRN who has completed the four-year CAPA-NS period, with RNs employed by the clinical entity. RN and investor founders usually own a management company that contracts with that practice for clinical services; the PC-MSO guide covers fair market value fees and why they should not track prescription volume.
Retainers in Louisville and Lexington run about $900–$1,600 per month. A physician who also signs an APRN’s CAPA-NS adds collaboration duties and usually charges more; see the medical director guide.
| Line item | Kentucky benchmark | Notes |
|---|---|---|
| Entity | Physician- or APRN-owned practice; MSO for investors | Professional corporation owners must be licensed |
| Medical director | $900–$1,600/mo | More if also signing a CAPA-NS |
| Prescriber assessment | $27–$35 per telehealth exam | Every new patient; repeat for Rx additives |
| Supplies per drip | $28–$55 | 503B stock or patient-specific 503A |
| Derby week staffing | 2 RNs per 6–10 guests | Book early in spring |
| Liability allocation | $150–$450/mo | Event and hotel certificates |
Model the numbers in the Kentucky provider calculator.
What the KBN advisory opinion means in practice
Kentucky Board of Nursing advisory opinion statements are the Board’s published interpretation of nursing scope under KRS Chapter 314. Its guidance on IV therapy, including elective IV hydration, expects the following, and operators should read the current statement on the KBN website because the Board revises these documents:
- An authorized prescriber assesses the patient and issues the order before IV therapy begins.
- The RN has documented education and competence in peripheral IV insertion, the specific fluids and drugs, and management of complications.
- Protocols are approved by the prescriber, and the RN does not select treatment independently.
- Emergency medications, equipment and a response plan are on site.
CAPA-NS, APRN prescribers and the GFE
Under KRS 314.042, a Kentucky APRN prescribes non-scheduled legend drugs, which covers ondansetron, ketorolac and standard vitamin additives, under a CAPA-NS with a physician for the first four years of prescribing. After four years, the APRN may prescribe non-scheduled drugs without a CAPA-NS after notifying the Board. Controlled substances still require a separate CAPA-CS. For IV businesses, a post-four-year APRN can perform the assessment and order the drip without a physician collaboration agreement for those drugs.
Because we classify Kentucky as strict for Good Faith Exams, plan on a synchronous prescriber assessment for each new patient and each prescription additive, with periodic renewal for unchanged wellness protocols. Telehealth assessments must meet KBML standards and be performed by a Kentucky-licensed prescriber. The GFE guide compares vendors.
Sourcing and Derby-week inventory
The Kentucky Board of Pharmacy permits pharmacies, including out-of-state pharmacies shipping into Kentucky, and regulates sterile compounding. Confirm that any 503A pharmacy filling patient-specific orders for your practice holds a Kentucky permit, and order stock vials and pre-mixed bags from an FDA-registered 503B outsourcing facility under the clinical practice’s account rather than the management company’s.
Derby week is the inventory test. A Louisville fleet can run several times its normal daily volume across the two weeks of the Kentucky Derby Festival, so order crystalloids, B-complex, magnesium and antiemetics early, and check beyond-use dates on glutathione and NAD+ before buying extra. Group events at hotels and private parties often run late into the evening; keep emergency medications stocked for every chair.
In-room mixing should stay within USP <797> immediate-use limits: three sterile components or fewer, administration begun within four hours, no bags prepared ahead for the next guest. Kentucky’s prescription monitoring program, KASPER, applies only to controlled substances, which standard IV menus do not contain. See the USP <797> guide.
Derby, bourbon and the Ohio River
Louisville’s year peaks in the two weeks around the Kentucky Derby on the first Saturday in May, when Churchill Downs, hotel parties and the Kentucky Derby Festival drive hydration and recovery bookings. Bourbon tourism along the Urban Bourbon Trail and distillery visits, and the Bourbon & Beyond festival in September, add group demand. Lexington follows Keeneland’s spring and fall race meets, University of Kentucky sports and the horse-farm and equine-industry calendar.
Northern Kentucky is part of the Cincinnati metro, and Louisville’s suburbs extend into southern Indiana. Ohio and Indiana share the compact with Kentucky, so a Louisville nurse can work Jeffersonville or Cincinnati visits on a multistate licence, with the order coming from a prescriber licensed in the patient’s state. Ohio also requires a Board of Pharmacy terminal distributor licence for the business that stocks the drugs.
Major Kentucky mobile IV & infusion markets
Louisville
- Lounge
- $145–$205
- Mobile
- $200–$290
- NAD+
- $340–$750
Derby week recovery, bourbon-tourism group bookings and September festival weekends.
Derby week fills downtown hotels and closes roads around Churchill Downs, so schedule mobile windows generously.
Lexington
- Lounge
- $145–$205
- Mobile
- $200–$290
- NAD+
- $340–$750
Keeneland race-meet recovery, college sports weekends and equine-industry corporate events.
Horse-farm properties outside the city add long rural drives.
Typical self-pay ranges per person; see the Kentucky drip estimator for group tiers and add-ons.
Book a mobile IV nurse or launch a practice in Kentucky
Patients and event hosts get licensed nurses with GFE screening arranged; clinics get matched with supervising physicians, GFE coverage and 503B supply.
Kentucky IV therapy FAQ
What does the Kentucky Board of Nursing say about IV hydration?
KBN advisory opinion guidance expects a prescriber assessment and order before IV therapy, documented RN competence, prescriber-approved protocols and emergency readiness. Read the current statement on the KBN website.
What is a CAPA-NS?
A Collaborative Agreement for the APRN’s Prescriptive Authority for Nonscheduled legend drugs, required for a Kentucky APRN’s first four years of prescribing under KRS 314.042.
Can a Kentucky APRN own an IV practice?
An APRN who has completed the CAPA-NS period can prescribe standard IV drugs without a physician collaboration agreement and often owns the practice. Confirm ownership structure with counsel.
Can Louisville nurses work in southern Indiana?
Yes on a multistate licence, since Indiana is a compact state. The order must come from an Indiana-licensed prescriber.
How much is a Derby week mobile IV?
Mobile drips in Louisville commonly run $200–$290 per person, with group discounts for parties and limited slots during Derby week.
Does a Kentucky APRN with a CAPA-NS still need a medical director?
Not to prescribe non-scheduled drugs once the four-year CAPA-NS period is complete, but many APRN-owned IV practices still contract a physician for higher-risk protocols such as NAD+ and for adverse-event consultation. Insurers may also ask who provides physician oversight.
Sources & standards reviewed
- Kentucky Board of Nursing advisory opinion statements on IV therapy Kentucky Board of Nursing
- KRS 314.042, APRN licensure and prescriptive authority Kentucky General Assembly
- KRS Chapter 311, physicians Kentucky Board of Medical Licensure
- KRS Chapter 315, pharmacists and pharmacies Kentucky Board of Pharmacy
- USP General Chapter <797> Pharmaceutical Compounding—Sterile Preparations USP
- Nurse Licensure Compact member states NCSBN
Reviewed under the IVConnection clinical and regulatory review policy. Report a correction to clinical@ivconnection.com.